Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

JANXJANX

Showing 2 of 5 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in Janux Therapeutics, Inc.

Yes. Connor, Clark & Lunn Investment Management holds 133,870 shares of JANX (Janux Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. It increased the position by 14,494 shares (+12.1%) from Q1 2026. Connor, Clark & Lunn Investment Management has held JANX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$2.1M

Current Shares

133,870

Total Value Change

+$396,917

Total Shares Change

+14,494

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
133,870
+12.1%
$2.1M0.0%$15.36
29
2026-Q1
New
119,376
—
$1.7M0.0%$13.90
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used